Costotransverse foramen block versus thoracic paravertebral block for pain control after lung cancer thoracotomy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Thoracotomy causes severe postoperative pain and reliable pain control is a major clinical challenge. This study compares a newer nerve block technique, the costotransverse foramen block (CTFB), with the established thoracic paravertebral block (TPVB) in patients undergoing thoracotomy for lung cancer. Eligible patients will receive either CTFB or TPVB as part of their perioperative analgesia and investigators will track postoperative pain scores, opioid consumption, and complications. The aim is to see if CTFB can match or improve pain control while reducing side effects and opioid use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years and ≤ 65 years old.
* American Society of Anesthesiologists (ASA) physical status II-III.
* Body mass index 18-35 kg/m2.
* Patients scheduled for thoracotomies for lung cancer.

Exclusion Criteria:

* Patient refusal.
* History of sensitivity to local anesthetics.
* History of psychological disorders.
* Contraindication to regional anesthesia, e.g., local sepsis, pre-existing peripheral neuropathies, and coagulopathy.
* Severe respiratory, cardiac, hepatic, or renal disease.
* Morbid obesity.
* Uncooperative patients.
* Patients on chronic pain therapy.

Where it's running

• Cairo University
  Cairo, Egypt Recruiting

Study contacts

• Study coordinator: Mai M Elrawas, MD
• Email: mai.elrawas@nci.cu.edu.eg
• Phone: 00201222177242

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden

  This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.

  Recruiting Tongji Hospital · Hubei, Wuhan · NCT07912190

• Urine VOC Test to Detect Lung Cancer in Never Smokers

  A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.

  Recruiting Thomas Jefferson University · Philadelphia, Pennsylvania · NCT07871656

• SI-B036 safety test in advanced and metastatic solid tumors

  This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.

  Recruiting at 4 sites Phase 1 SystImmune Inc. · New Haven, Connecticut and 6 other locations · NCT07857616

• Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment

  This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07816263

• ENPP1/cGAS and FAP in Solid Tumors in Vietnamese Patients

  This Vietnam-based study will test ENPP1, cGAS, and FAP expression in archived tumor samples from Vietnamese adults with solid cancers using immunohistochemistry.

  Recruiting at 2 sites Tam Anh Research Institute · Hanoi, Hanoi and 1 other locations · NCT07808164

• Olive oil before lung cancer surgery to see if it lowers chylothorax

  This study tests whether drinking 40 mL of extra-virgin olive oil a few hours before lung cancer surgery can reduce chylothorax after tumor removal.

  Recruiting Fudan University · Shanghai, Xuhui · NCT07807696

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.